Importance The identification and validation of biomarkers in hidradenitis suppurativa (HS)
has potential to improve the understanding and management of this chronic, burdensome …

Introduction Partly due to its clinical heterogeneity, hidradenitis suppurativa (HS) is difficult to
score accurately; illustrated by the large number of disease scores. In 2016, a systematic …

Abstract Research interest in Hidradenitis Suppurativa (HS) has grown exponentially over
the past decades. Several groups have worked to develop novel scores that address the …

Hidradenitis suppurativa (HS) is a heterogeneous chronic relapsing skin disease. Several
assessment tools are used to assess disease severity and to classify disease phenotype; …

Background Therapeutic options for mild hidradenitis suppurativa (HS) represent a
significant gap in the current treatment landscape, with no FDA approved therapies for early …

International consensus definition of disease flare in hidradenitis suppurativa | British Journal of
Dermatology | Oxford Academic Skip to Main Content Advertisement intended for healthcare …

Introduction This second part of the S2k guidelines is an update of the 2015 S1 European
guidelines. Objective These guidelines aim to provide an accepted decision aid for the …

Importance Pain is the most impactful symptom in patients with hidradenitis suppurativa
(HS). Characterization of sensory profiles may improve understanding of pain mechanisms …

Patient-reported outcomes (PROs) provide quantitative assessments of patients'
experiences with their skin diseases. PROs are usually much more comprehensive than …

Hidradenitis suppurativa (HS) is an inflammatory disorder characterized by chronic deep-
seated nodules, abscesses, fistulae, sinus tracts, and scars in apocrine gland-bearing …